I’ve followed Natera for years. I sold the position earlier (+90% profit) to concentrate into SpaceX, Lilly & Pershing Square. After the Q3 volume trajectory and guidance raise, the CEO transition, and the subsequent drop, I’m getting back in. The core volume and evidence story is intact and the leadership handoff is internal. The post-earnings drop giv…
Natera: Q3 2026 Research Update. I´m back in!
Why the sell-off is an entry, not an exit.
Subscribe for free to continue reading
Enter your email and get every post from FJ Research.



